Lid06 0006 01
Lidocaine
Product Images NDC 17478-711
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine (NDC 17478-711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lid06 0006 02
This is a Lidocaine Hydrochloride Jelly USP used for topical application only. The jelly contains Lidocaine Hydrochloride (2%) and some other substances such as hypromellose, methyl and propylparabens, sodium hydroxide, and/or hydrochloric acid. The package insert should be consulted for proper dosage information. The jelly is stored at a controlled room temperature and lot number and expiration date information can be found on the crimp closure. This product is not suitable for ophthalmic use.*
Lid06 0006 03
NDC 17478-711-10 Sterile 5 mL Lidocaine Hydrochloride Jelly USP, 2% R only. Lidocaine HCI Jelly 2% is a sterile aqueous solution of lidocaine hydrochloride, hypromellose, methyl, and propylparaben, sodium hydroxide and/or hydrochloric acid to adjust pH between 6.0 to 7.0. Usual Dosage: See package insert for dosage information. Storage: Store at 20" to 25°C (68" to 77°F) [see USP Controlled Room Temperature]. For topical use only. Not for ophthalmic use. Discard unused portion. Manufactured by: Akorn, Inc., Lake Forest, IL60045 LDAAC Rev.06/16 |*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
